FDA Drug Application (021023) for RESTASIS by ALLERGAN

Back to FDA Applications sponsored by ALLERGAN

Application Number021023
Product Number001
FormEMULSION; OPHTHALMIC
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRESTASIS
Active IngredientCYCLOSPORINE

Active IngredientCount
List of drugs with Active Ingredient CYCLOSPORINE5


Back to FDA Applications sponsored by ALLERGAN